0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA Oncology | 
Editorial |  ONLINE FIRST
Elizabeth C. Smyth, MB, BCh, MSc; Khurum Khan, MBBS; David Cunningham, FMedSci
JAMA Oncol. Published online February 11, 2016. doi:10.1001/jamaoncol.2015.6274

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Jenny F. Seligmann, PhD; Faye Elliott, MSc; Susan D. Richman, PhD; et al.
JAMA Oncol. Published online February 11, 2016. doi:10.1001/jamaoncol.2015.6065
Includes: Supplemental Content

JAMA Dermatology | 
Observation |  ONLINE FIRST
Ji Won Ahn, BA; Katherine Johnson, DO; Laurie L. Kohen, MD; et al.
JAMA Dermatol. Published online February 10, 2016. doi:10.1001/jamadermatol.2015.5702

JAMA Internal Medicine | 
Research Letter |  ONLINE FIRST
Michael E. Zavaski, MD; Christian P. Meyer, MD; Jesse D. Sammon, DO; et al.
JAMA Intern Med. Published online February 08, 2016. doi:10.1001/jamainternmed.2015.7901

JAMA Oncology | 
Editorial | 
Jee Ye Kim, MD; Seung-il Kim, MD, PhD; Soonmyung Paik, MD
JAMA Oncol. 2016;2(2):180-182. doi:10.1001/jamaoncol.2015.4343.

JAMA Oncology | 
Original Investigation | 
Michail Ignatiadis, MD, PhD; Hatem A. Azim Jr, MD, PhD; Christine Desmedt, PhD; et al.
JAMA Oncol. 2016;2(2):217-224. doi:10.1001/jamaoncol.2015.4377.
Includes: Supplemental Content

JAMA Oncology | 
Invited Commentary |  ONLINE FIRST
Dirk Klingbiel, PhD; Sabine Tejpar, MD, PhD
JAMA Oncol. Published online January 14, 2016. doi:10.1001/jamaoncol.2015.5226

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Julien Taieb, MD, PhD; Aziz Zaanan, MD, PhD; Karine Le Malicot, MS; et al.
JAMA Oncol. Published online January 14, 2016. doi:10.1001/jamaoncol.2015.5225
Includes: Supplemental Content

JAMA Dermatology | 
Brief Report |  ONLINE FIRST
Mina S. Ally, MD; Katherine Ransohoff, BA; Kavita Sarin, MD, PhD; et al.
JAMA Dermatol. Published online January 13, 2016. doi:10.1001/jamadermatol.2015.5473
Includes: Supplemental Content

JAMA Oncology | 
Invited Commentary |  ONLINE FIRST
Sean E. McGuire, MD, PhD
JAMA Oncol. Published online January 07, 2016. doi:10.1001/jamaoncol.2015.4952

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Editorial  | 
AREG and EREG as Predictive Biomarkers for RAS Wild-Type Colorectal Cancer Treated With Panitumumab A Fresh Approach to an Old Puzzle
Elizabeth C. Smyth, MB, BCh, MSc; Khurum Khan, MBBS; David Cunningham, FMedSci
JAMA Oncology
Original Investigation  | 
Combined Epiregulin and Amphiregulin Expression Levels as a Predictive Biomarker for Panitumumab Therapy Benefit or Lack of Benefit in Patients With RAS Wild-Type Advanced Colorectal Cancer
Jenny F. Seligmann, PhD; Faye Elliott, MSc; Susan D. Richman, PhD; et al.
JAMA Dermatology
Observation  | 
Melanoma Gene Expression Markers for Surveillance of Epidermolysis Bullosa Nevi Malignant Transformation
Ji Won Ahn, BA; Katherine Johnson, DO; Laurie L. Kohen, MD; et al.
JAMA Internal Medicine
Research Letter  | 
Differences in Prostate-Specific Antigen Testing Among Urologists and Primary Care Physicians Following the 2012 USPSTF Recommendations
Michael E. Zavaski, MD; Christian P. Meyer, MD; Jesse D. Sammon, DO; et al.